BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

948 related articles for article (PubMed ID: 24394725)

  • 21. Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes.
    Yaneva M; Mosnier-Pudar H; Dugué MA; Grabar S; Fulla Y; Bertagna X
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3345-51. PubMed ID: 15240613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The value of corticotropin-releasing hormone (CRH) test for differential diagnosis of Cushing's syndrome].
    Penezić Z; Zarković M; Vujović S; Ivović M; Beleslin B; Ciric J; Drezgić M
    Srp Arh Celok Lek; 2007; 135(1-2):31-7. PubMed ID: 17503565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cushing's Syndrome: Screening and Diagnosis.
    Ceccato F; Boscaro M
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):209-15. PubMed ID: 27160717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical utility of late-night and post-overnight dexamethasone suppression salivary cortisone for the investigation of Cushing's syndrome.
    Ng CM; Lam TK; Au Yeung YC; Choi CH; Iu YP; Shek CC; Tiu SC
    Hong Kong Med J; 2017 Dec; 23(6):570-8. PubMed ID: 29026058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC; Raff H; Findling JW
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test differentiates mild Cushing's disease from normal physiology.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    J Clin Endocrinol Metab; 1998 Feb; 83(2):348-52. PubMed ID: 9467539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of CRH stimulation test and overnight 8 mg dexamethasone suppression test in 469 patients with ACTH-dependent Cushing's syndrome.
    Detomas M; Ritzel K; Nasi-Kordhishti I; Wolfsberger S; Quinkler M; Losa M; Tröger V; Kroiss M; Fassnacht M; Vila G; Honegger JB; Reincke M; Deutschbein T
    Front Endocrinol (Lausanne); 2022; 13():955945. PubMed ID: 36277711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of non-invasive dynamic tests in the diagnosis of Cushing's syndrome.
    Vilar L; Freitas MC; Naves LA; Canadas V; Albuquerque JL; Botelho CA; Egito CS; Arruda MJ; Silva LM; Arahata CM; Agra R; Lima LH; Azevedo M; Casulari LA
    J Endocrinol Invest; 2008 Nov; 31(11):1008-13. PubMed ID: 19169058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The limited value of the desmopressin test in the diagnostic approach to Cushing's syndrome.
    Terzolo M; Reimondo G; Alì A; Borretta G; Cesario F; Pia A; Paccotti P; Angeli A
    Clin Endocrinol (Oxf); 2001 May; 54(5):609-16. PubMed ID: 11380491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the dexamethasone-suppressed corticotropin-releasing hormone test and low-dose dexamethasone suppression test in the diagnosis of Cushing's syndrome.
    Martin NM; Dhillo WS; Banerjee A; Abdulali A; Jayasena CN; Donaldson M; Todd JF; Meeran K
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2582-6. PubMed ID: 16670165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
    Yap LB; Turner HE; Adams CB; Wass JA
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing's syndrome.
    Valassi E; Swearingen B; Lee H; Nachtigall LB; Donoho DA; Klibanski A; Biller BM
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4851-9. PubMed ID: 19850679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Endogenous Cushing's syndrome: clinical and laboratorial features in 73 cases].
    Vilar L; Naves LA; Freitas Mda C; Moura E; Canadas V; Leal E; Teixeira L; Gusmão A; Santos V; Campos R; Lima M; Paiva R; Albuquerque JL; Egito CS; Botelho CA; Lyra R; Azevedo MF; Casulari LA
    Arq Bras Endocrinol Metabol; 2007 Jun; 51(4):566-74. PubMed ID: 17684617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma, and adrenal insufficiency.
    Ceccato F; Barbot M; Zilio M; Ferasin S; Occhi G; Daniele A; Mazzocut S; Iacobone M; Betterle C; Mantero F; Scaroni C
    Eur J Endocrinol; 2013 Jul; 169(1):31-6. PubMed ID: 23610124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
    Newell-Price J; Perry L; Medbak S; Monson J; Savage M; Besser M; Grossman A
    J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The corticotropin-releasing hormone test in the diagnosis of ACTH-dependent Cushing's syndrome: a reappraisal.
    Pecori Giraldi F; Invitti C; Cavagnini F;
    Clin Endocrinol (Oxf); 2001 May; 54(5):601-7. PubMed ID: 11380490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The discriminatory value of the low-dose dexamethasone suppression test in the investigation of paediatric Cushing's syndrome.
    Dias R; Storr HL; Perry LA; Isidori AM; Grossman AB; Savage MO
    Horm Res; 2006; 65(3):159-62. PubMed ID: 16514243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Out-patient screening for Cushing's syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests.
    Castro M; Elias PC; Quidute AR; Halah FP; Moreira AC
    J Clin Endocrinol Metab; 1999 Mar; 84(3):878-82. PubMed ID: 10084565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The differential diagnosis of Cushing's syndrome.
    Newell-Price J; Grossman AB
    Ann Endocrinol (Paris); 2001 Apr; 62(2):173-9. PubMed ID: 11353890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing's disease.
    Tirabassi G; Faloia E; Papa R; Furlani G; Boscaro M; Arnaldi G
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1115-22. PubMed ID: 20080839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.